1
|
Kang JL, Wang XX, Nie ML and Huang XH:
Efficacy of gonadotropin-releasing hormone agonist and an
extended-interval dosing regimen in the treatment of patients with
adenomyosis and endometriosis. Gynecol Obstet Invest. 69:73–77.
2010. View Article : Google Scholar : PubMed/NCBI
|
2
|
Soto E, Luu TH, Liu X, Magrina JF, Wasson
MN, Einarsson JI, Cohen SL and Falcone T: Laparoscopy vs. Robotic
Surgery for Endometriosis (LAROSE): A multicenter, randomized,
controlled trial. Fertil Steril. 107:996–1002 e1003. 2017.
View Article : Google Scholar : PubMed/NCBI
|
3
|
Nematian SE, Mamillapalli R, Kadakia TS,
Majidi Zolbin M, Moustafa S and Taylor HS: Systemic inflammation
induced by microRNAs: Endometriosis derived alterations in
circulating microRNA 125b-5p and let7b-5p regulate macrophage
cytokine production. J Clin Endocrinol Metab. 103:64–74. 2018.
View Article : Google Scholar : PubMed/NCBI
|
4
|
Shen L, Yang S, Huang W, Xu W, Wang Q,
Song Y and Liu Y: MicroRNA23a and microRNA23b deregulation
derepresses SF-1 and upregulates estrogen signaling in ovarian
endometriosis. J Clin Endocrinol Metab. 98:1575–1582. 2013.
View Article : Google Scholar : PubMed/NCBI
|
5
|
Wright KR, Mitchell B and Santanam N:
Redox regulation of microRNAs in endometriosis-associated pain.
Redox Biol. 12:956–966. 2017. View Article : Google Scholar : PubMed/NCBI
|
6
|
Zhang L, Xiong W, Xiong Y, Liu H, Li N, Du
Y and Liu Y: Intracellular wnt/beta-catenin signaling underlying
17beta-estradiol-induced matrix metalloproteinase 9 expression in
human endometriosis. Biol Reprod. 94:702016. View Article : Google Scholar : PubMed/NCBI
|
7
|
Pazhohan A, Amidi F, Akbari-Asbagh F,
Seyedrezazadeh E, Farzadi L, Khodarahmin M, Mehdinejadiani S and
Sobhani A: The Wnt/β-catenin signaling in endometriosis, the
expression of total and active forms of β-catenin, total and
inactive forms of glycogen synthase kinase-3β, WNT7a and
DICKKOPF-1. Eur J Obstet Gynecol Reprod Biol. 220:1–5. 2017.
View Article : Google Scholar : PubMed/NCBI
|
8
|
Zhang P, Sun Y and Ma L: ZEB1: At the
crossroads of epithelial-mesenchymal transition, metastasis and
therapy resistance. Cell Cycle. 14:481–487. 2015. View Article : Google Scholar : PubMed/NCBI
|
9
|
Schmalhofer O, Brabletz S and Brabletz T:
E-cadherin, beta-catenin, and ZEB1 in malignant progression of
cancer. Cancer Metastasis Rev. 28:151–166. 2009. View Article : Google Scholar : PubMed/NCBI
|
10
|
Browne G, Sayan AE and Tulchinsky E: ZEB
proteins link cell motility with cell cycle control and cell
survival in cancer. Cell Cycle. 9:886–891. 2010. View Article : Google Scholar : PubMed/NCBI
|
11
|
Eggers JC, Martino V, Reinbold R, Schäfer
SD, Kiesel L, Starzinski-Powitz A, Schüring AN, Kemper B, Greve B
and Götte M: microRNA miR-200b affects proliferation, invasiveness
and stemness of endometriotic cells by targeting ZEB1, ZEB2 and
KLF4. Reprod Biomed Online. 32:434–445. 2016. View Article : Google Scholar : PubMed/NCBI
|
12
|
Wang ZH, Zhang JL, Duan YL, Zhang QS, Li
GF and Zheng DL: MicroRNA-214 participates in the neuroprotective
effect of resveratrol via inhibiting α-synuclein expression in
MPTP-induced Parkinson's disease mouse. Biomed Pharmacother.
74:252–256. 2015. View Article : Google Scholar : PubMed/NCBI
|
13
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
14
|
Maegdefessel L, Spin JM, Raaz U, Eken SM,
Toh R, Azuma J, Adam M, Nakagami F, Heymann HM, Chernogubova E, et
al: miR-24 limits aortic vascular inflammation and murine abdominal
aneurysm development. Nat Commun. 5:52142014. View Article : Google Scholar : PubMed/NCBI
|
15
|
Nothnick WB: MicroRNAs and endometriosis:
Distinguishing drivers from passengers in disease pathogenesis.
Semin Reprod Med. 35:173–180. 2017. View Article : Google Scholar : PubMed/NCBI
|
16
|
Matsuzaki S and Darcha C: Involvement of
the Wnt/β-catenin signaling pathway in the cellular and molecular
mechanisms of fibrosis in endometriosis. PLoS One. 8:e768082013.
View Article : Google Scholar : PubMed/NCBI
|
17
|
Tanwar PS, Lee HJ, Zhang L, Zukerberg LR,
Taketo MM, Rueda BR and Teixeira JM: Constitutive activation of
Beta-catenin in uterine stroma and smooth muscle leads to the
development of mesenchymal tumors in mice. Biol Reprod. 81:545–552.
2009. View Article : Google Scholar : PubMed/NCBI
|
18
|
Zhang L, Xiong W, Xiong Y, Liu H and Liu
Y: 17 beta-Estradiol promotes vascular endothelial growth factor
expression via the Wnt/β-catenin pathway during the pathogenesis of
endometriosis. Mol Hum Reprod. 22:526–535. 2016. View Article : Google Scholar : PubMed/NCBI
|
19
|
Matsuzaki S and Darcha C: In vitro effects
of a small-molecule antagonist of the Tcf/ß-catenin complex on
endometrial and endometriotic cells of patients with endometriosis.
PLoS One. 8:e616902013. View Article : Google Scholar : PubMed/NCBI
|
20
|
Wang S and Ren D: Allicin protects
traumatic spinal cord injury through regulating the HSP70/Akt/iNOS
pathway in mice. Mol Med Rep. 14:3086–3092. 2016. View Article : Google Scholar : PubMed/NCBI
|
21
|
Furuya M, Masuda H, Hara K, Uchida H, Sato
K, Sato S, Asada H, Maruyama T, Yoshimura Y, Katabuchi H, et al:
ZEB1 expression is a potential indicator of invasive endometriosis.
Acta Obstet Gynecol Scand. 96:1128–1135. 2017. View Article : Google Scholar : PubMed/NCBI
|
22
|
Panda H, Pelakh L, Chuang TD, Luo X,
Bukulmez O and Chegini N: Endometrial miR-200c is altered during
transformation into cancerous states and targets the expression of
ZEBs, VEGFA, FLT1, IKKbeta, KLF9, and FBLN5. Reprod Sci.
19:786–796. 2012. View Article : Google Scholar : PubMed/NCBI
|